The complex fac -[PtMe 3 (SO 3 CF 3 )(bu 2 bpy)] ( 1 ) (bu 2 bpy = 4,4‘-di- tert -butyl-2,2‘-bipyridine) reacts with NaBH 4 to give [Pt 2 (μ-H)Me 6 (bu 2 bpy) 2 ]SO 3 CF 3 ( 2 ), which is the first example of a (μ-hydrido)diplatinum(IV) complex. Complex 2 was fully characterized on the basis of microanalytical, 1 H and 195 Pt NMR spectroscopic, and X-ray crystallographic data. The reaction of 1 with a large excess of NaBH 4 results in the formation of an equilibrium mixture of 2 and fac -[PtHMe 3 (bu 2 bpy)] ( 3 ). Complex 3 was characterized by 1 H NMR spectroscopy in solution but could not be isolated in pure form due to the ease of reversion to 2 . Both complexes 2 and 3, which have no ligand that can easily dissociate, are thermally stable to reductive elimination of methane (both in solution and, in the case of complex 2, in the solid state) and to isotopic exchange within Pt(D)CH 3 groups, thus giving strong support to the theory that both reactions must occur from within a five-coordinate intermediate. Complex 2 reacts slowly with HX (HX = HCl, HO 2 CCF 3, HSC 6 H 5, NH 4 + ) to give either 2 equiv of fac -[PtClMe 3 (bu 2 bpy)] ( 4 ), fac - [PtMe 3 (O 2 CCF 3 )(bu 2 bpy)]( 5 ), and fac -[PtMe 3 (NH 3 )(bu 2 bpy)]SO 3 CF 3 ( 6 ) or 1 equiv of [Pt 2 (μ- S C 6 H 5 )Me 6 (bu 2 bpy) 2 ]SO 3 CF 3 ( 7 ), respectively. Qualitatively, the relative rates of these reactions follow the order of acid strength, i.e. HCl ≈ HO 2 CCF 3 ≫ HSC 6 H 5, indicating that the rate-determining step involves electrophilic attack of H + on 2 . Complex 2 reacts very slowly with nucleophiles such as PPh 3 to give 1 equiv of fac -[PtMe 3 (PPh 3 )(bu 2 bpy)]SO 3 CF 3 ( 8 ) and 1 equiv of 3 . The reaction of CCl 4 with 2 gives fac -[PtClMe 3 (bu 2 bpy)] ( 4 ), [PtCl 2 Me 2 (bu 2 bpy)] ( 11 ), and mer -[PtCl 3 Me(bu 2 bpy)] ( 12) in a 1.0:0.8:0.2 product ratio but without formation of chloroform.
No takes yet. Share an insight, caveat, or question.
Hill et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: